Corline Biomedical AB announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced total revenue was SEK 2.763 million compared to SEK 4.294 million a year ago. Operating loss was SEK 1.405 million compared to SEK 2.507 million a year ago. Net loss was SEK 1.405 million compared to SEK 2.507 million a year ago. Basic loss per share from continuing operations was SEK 0.08 compared to SEK 0.15 a year ago.